On September 10, 2020 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, reported that Brian M. Culley, Chief Executive Officer will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 at 3:00 pm Eastern Time / 12:00 pm Pacific Time (Press release, Lineage Cell Therapeutics, SEP 10, 2020, View Source [SID1234564932]). Mr. Culley and Brandi L. Roberts, Chief Financial Officer, will also be presenting at the 2020 Cantor Virtual Global Healthcare Conference on September 17, 2020 at 12:00 pm Eastern Time / 9:00 am Pacific Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interested investors can access both live presentations on the Events and Presentations section of Lineage’s website and archived presentations will be available for 30 days. Additional videos are available on the Media page of the Lineage website, located at www.lineagecell.com/media/.